Summary
- Revenue
- CNTA current annual revenue is $15.04M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for CNTA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Centessa Pharmaceuticals plc |
| Ticker | NASDAQ: CNTA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | centessa.com |
| Employees | 86 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $15.04M | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.46 | ||
| EPS, 1Y Change | +29.19% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.46 | ||
| EPS Estimate | -$1.56 | N/A |
| EPS Est. Change | -6.93% | N/A |
| $15.04M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | - | |
| Price Target | $39.00 | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.43 | -$2.06 | -44.08% | |
| -$1.35 | -$1.46 | -8.15% | |
| -$1.56 | N/A | -6.93% | |
| -$1.78 | N/A | -22.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $14.55M | $15.04M | +3.30% | |
| - | N/A | - | |
| $28.57M | N/A | +90.03% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $15.04M | ||
| -$1.46 | ||
| $14.11M | ||
| 93.86% | ||
| -$208.18M | ||
| -1,384.61% | ||
| -$197.99M | ||
| -1,316.88% | ||
| -$207.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.22 | ||
| 8.57 | ||
| 8.57 | ||
| - | ||
| - | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $526.86M | ||
| $294.58M | ||
| $690.20M | ||
| $367.88M | ||
| $163.34M | ||
| $42.94M | ||
| $118.38M | ||
| $713.00K | ||
| $7.58M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $213.03M | ||
| $222.29M | ||
| $923.20K | ||
| $50.59M | ||
| $923.20K | ||
| $0.00 | ||
| $1.82M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$194.27M | ||
| -$419.51M | ||
| $292.21M | ||
| $371.90K | ||
| -$194.64M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| Guggenheim | → | |
| Leerink Partners | → | |
| Wolfe Research | → | |
| Needham | → | |
| Wolfe Research | ||
| Truist Securities | → | |
| Truist Securities | → | |
| Chardan Capital | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
No data
Screeners with CNTA
FAQ
- What is the ticker symbol for Centessa Pharmaceuticals plc?
- The ticker symbol for Centessa Pharmaceuticals plc is NASDAQ:CNTA
- Does Centessa Pharmaceuticals plc pay dividends?
- No, Centessa Pharmaceuticals plc does not pay dividends
- What sector is Centessa Pharmaceuticals plc in?
- Centessa Pharmaceuticals plc is in the Healthcare sector
- What industry is Centessa Pharmaceuticals plc in?
- Centessa Pharmaceuticals plc is in the Biotechnology industry
- What country is Centessa Pharmaceuticals plc based in?
- Centessa Pharmaceuticals plc is headquartered in United Kingdom
- When did Centessa Pharmaceuticals plc go public?
- Centessa Pharmaceuticals plc initial public offering (IPO) was on May 28, 2021
- Is Centessa Pharmaceuticals plc in the S&P 500?
- No, Centessa Pharmaceuticals plc is not included in the S&P 500 index
- Is Centessa Pharmaceuticals plc in the NASDAQ 100?
- No, Centessa Pharmaceuticals plc is not included in the NASDAQ 100 index
- Is Centessa Pharmaceuticals plc in the Dow Jones?
- No, Centessa Pharmaceuticals plc is not included in the Dow Jones index
- When was Centessa Pharmaceuticals plc last earnings report?
- Centessa Pharmaceuticals plc's most recent earnings report was on August 11, 2026
- When does Centessa Pharmaceuticals plc report earnings?
- The date for Centessa Pharmaceuticals plc's next earnings report has not been announced yet
Data Sources & References
- CNTA Official Website centessa.com
- CNTA Profile on Yahoo Finance finance.yahoo.com/quote/CNTA
- CNTA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cnta
